Charlottesville, VA2 Active Studies

Atrial Fibrillation Clinical Trials in Charlottesville, VA

Find 2 actively recruiting atrial fibrillation clinical trials in Charlottesville, VA. Connect with local research sites and explore new treatment options.

2
Active Trials
2
Sponsors
370
Enrolling

Recruiting Atrial Fibrillation Studies in Charlottesville

About Atrial Fibrillation Clinical Trials in Charlottesville

Atrial fibrillation (AFib) is the most common type of heart arrhythmia, causing an irregular and often rapid heartbeat. It significantly increases the risk of stroke, heart failure, and other complications. Treatment includes blood thinners, heart rate or rhythm control medications, and procedures like ablation.

There are currently 2 atrial fibrillation clinical trials recruiting participants in Charlottesville, VA. These studies are seeking a combined 370 participants. Research is being sponsored by CardioFocus, H. Lee Moffitt Cancer Center and Research Institute. Clinical trial participation is free and participants receive study-related medical care at no cost.

Atrial Fibrillation Clinical Trials in Charlottesville — FAQ

Are there atrial fibrillation clinical trials in Charlottesville?

Yes, there are 2 atrial fibrillation clinical trials currently recruiting in Charlottesville, VA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Charlottesville?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Charlottesville research site will contact you about next steps.

Are clinical trials in Charlottesville free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Charlottesville studies also compensate for your time and travel.

What atrial fibrillation treatments are being tested?

The 2 active trials in Charlottesville are testing new therapies including novel drugs, biologics, and treatment approaches for atrial fibrillation.

Data updated July 18, 2026 from ClinicalTrials.gov